Sponsored For
Beginners Choice

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Mastercard Incorporated is a credit services business based in the US. Mastercard Incorporated shares (MA) are listed on the NYSE and all prices are listed in US Dollars. Mastercard Incorporated employs 18,600 staff and has a trailing 12-month revenue of around USD$15.6 billion.
Since the stock market crash in March caused by coronavirus, Mastercard Incorporated's share price has had significant negative movement.
Its last market close was USD$333.6, which is 1.80% down on its pre-crash value of USD$339.7 and 66.81% up on the lowest point reached during the March crash when the shares fell as low as USD$199.99.
If you had bought USD$1,000 worth of Mastercard Incorporated shares at the start of February 2020, those shares would have been worth USD$626.16 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,027.49.
Latest market close | USD$333.6 |
---|---|
52-week range | USD$198.9308 - USD$366.3585 |
50-day moving average | USD$340.9164 |
200-day moving average | USD$329.538 |
Wall St. target price | USD$373.69 |
PE ratio | 50.2702 |
Dividend yield | USD$1.76 (0.51%) |
Earnings per share (TTM) | USD$6.663 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the last close of $333.6
1 week (2021-01-12) | -2.72% |
---|---|
1 month (2020-12-18) | -1.98% |
3 months (2020-10-19) | 0.58% |
6 months (2020-07-17) | 9.72% |
1 year (2020-01-17) | 3.07% |
---|---|
2 years (2019-01-18) | 65.15% |
3 years (2018-01-19) | 99.96% |
5 years (2016-01-19) | 286.92% |
Valuing Mastercard Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mastercard Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mastercard Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 50x. In other words, Mastercard Incorporated shares trade at around 50x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Mastercard Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.1004. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Mastercard Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Mastercard Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$9 billion.
The EBITDA is a measure of a Mastercard Incorporated's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | USD$15.6 billion |
---|---|
Operating margin TTM | 54.2% |
Gross profit TTM | USD$16.9 billion |
Return on assets TTM | 18.35% |
Return on equity TTM | 123.07% |
Profit margin | 43.13% |
Book value | $5.81 |
Market capitalisation | USD$333.9 billion |
TTM: trailing 12 months
There are currently 3.9 million Mastercard Incorporated shares held short by investors – that's known as Mastercard Incorporated's "short interest". This figure is 32% down from 5.7 million last month.
There are a few different ways that this level of interest in shorting Mastercard Incorporated shares can be evaluated.
Mastercard Incorporated's "short interest ratio" (SIR) is the quantity of Mastercard Incorporated shares currently shorted divided by the average quantity of Mastercard Incorporated shares traded daily (recently around 3.4 million). Mastercard Incorporated's SIR currently stands at 1.12. In other words for every 100,000 Mastercard Incorporated shares traded daily on the market, roughly 1120 shares are currently held short.
However Mastercard Incorporated's short interest can also be evaluated against the total number of Mastercard Incorporated shares, or, against the total number of tradable Mastercard Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Mastercard Incorporated's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Mastercard Incorporated shares in existence, roughly 0 shares are currently held short) or 0.0044% of the tradable shares (for every 100,000 tradable Mastercard Incorporated shares, roughly 4 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Mastercard Incorporated.
Steps to owning and managing Vaxart shares from Ireland.
Steps to owning and managing Takeda Pharmaceutical shares from Ireland.
Steps to owning and managing Sinovac Biotech Ltd shares from Ireland.
Steps to owning and managing Mesoblast shares from Ireland.
Steps to owning and managing Inovio Pharmaceuticals shares from Ireland.
Steps to owning and managing Heat Biologics shares from Ireland.
Steps to owning and managing CytoDyn shares from Ireland.
Steps to owning and managing Cynata Therapeutics shares from Ireland.
Steps to owning and managing BioNTech shares from Ireland.
Steps to owning and managing Atomo Diagnostics shares from Ireland.